[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 7, Issue 1 (Int J Mol Cell Med 2018) ::
Int J Mol Cell Med 2018, 7(1): 17-23 Back to browse issues page
A Comprehensive Genetic and Clinical Evaluation of Waardenburg Syndrome Type II in a Set of Iranian Patients
Nazanin Jalilian 1, Mohammad Amin Tabatabaiefar 2, Mahboubeh Yazdanpanah 3, Elham Darabi 4, Tayyeb Bahrami 3, Ali Zekri 5, Mohammad Reza Noori-Daloii * 6
1- Department of Clinical biochemistry, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
2- Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
3- Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
4- Department of Medical Genetics, School of Medicine, International Campus, Tehran University of Medical Sciences, Tehran, Iran.
5- Department of Medical Genetics and Molecular Biology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.
6- Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. , nooridaloii@tums.ac.ir
Abstract:   (954 Views)
Waardenburg syndrome (WS) is a neurocristopathy with an autosomal dominant mode of inheritance, and considerable clinical and genetic heterogeneity. WS type II is the most common type of WS in many populations presenting with sensorineural hearing impairment, heterochromia iridis, hypoplastic blue eye, and pigmentary abnormalities of the hair and skin. To date, mutations of MITF, SOX10, and SNAI2 have been implicated in the pathogenesis of WS2. Although different pathogenic mutations have been reported in many ethnic groups, the data on Iranian WS2 patients is insufficient. 31 WS2 patients, including 22 men and 9 women from 14 families were included. Waardenburg consortium guidelines were employed for WS2 diagnosis. WS2 patients underwent screening for MITF, SOX10, and SNAI2 mutations using direct sequencing and MLPA analysis. Clinical evaluation revealed prominent phenotypic variability in Iranian WS2 patients. Sensorineural hearing impairment and heterochromia iridis were the most common features (67% and 45%, respectively), whereas anosmia was the least frequent phenotype. Molecular analysis revealed a de novo heterozygous c.640C>T (p.R214X) in MITF and a de novo heterozygous SOX10 gross deletion in the study population. Our data help illuminate the phenotypic and genotypic spectrum of WS2 in an Iranian series of patients, and could have implications for the genetic counseling of WS in Iran.
Keywords: Waardenburg syndrome type 2, Iran, MLPA, gene deletion, mutation
Full-Text [PDF 524 kb]   (281 Downloads)    
Type of Study: Original Article | Subject: Genetics & Disease
Received: 2018/01/6 | Accepted: 2018/03/23 | Published: 2018/03/27
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA code



XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Jalilian N, Tabatabaiefar M A, Yazdanpanah M, Darabi E, Bahrami T, Zekri A et al . A Comprehensive Genetic and Clinical Evaluation of Waardenburg Syndrome Type II in a Set of Iranian Patients. Int J Mol Cell Med. 2018; 7 (1) :17-23
URL: http://ijmcmed.org/article-1-798-en.html


Volume 7, Issue 1 (Int J Mol Cell Med 2018) Back to browse issues page
International Journal of Molecular and Cellular Medicine (IJMCM) International Journal of Molecular and Cellular Medicine (IJMCM)
Persian site map - English site map - Created in 0.07 seconds with 30 queries by YEKTAWEB 3755